Merck & Co., Inc. (MRK) stock
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30285% above fair value
$144.46−3.30 (-2.23%)
Close on Nov 16, 2026Market cap $356.41BP/E 115.6Yield 2.27%
Merck total assets
Total assets on the balance sheet at the end of each period.
Merck's total assets was $129.80B at Jun 30, 2026. For fiscal 2025 it was $136.87B, up 16.9% from the year before. Over ten years it grew 3.0% a year on average. The highest annual figure on record is $136.87B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $136.87B | +16.9% |
| FY2024 | Dec 31, 2024 | $117.11B | +9.8% |
| FY2023 | Dec 31, 2023 | $106.68B | -2.3% |
| FY2022 | Dec 31, 2022 | $109.16B | +3.3% |
| FY2021 | Dec 31, 2021 | $105.69B | +15.4% |
| FY2020 | Dec 31, 2020 | $91.59B | +8.5% |
| FY2019 | Dec 31, 2019 | $84.40B | +2.1% |
| FY2018 | Dec 31, 2018 | $82.64B | -6.0% |
| FY2017 | Dec 31, 2017 | $87.87B | -7.9% |
| FY2016 | Dec 31, 2016 | $95.38B | -6.2% |
| FY2015 | Dec 31, 2015 | $101.68B | +3.6% |
| FY2014 | Dec 31, 2014 | $98.17B | -7.1% |
| FY2013 | Dec 31, 2013 | $105.65B | -0.5% |
| FY2012 | Dec 31, 2012 | $106.13B | +1.0% |
| FY2011 | Dec 31, 2011 | $105.13B | -0.6% |
| FY2010 | Dec 31, 2010 | $105.78B | -5.8% |
| FY2009 | Dec 31, 2009 | $112.31B | +138.0% |
| FY2008 | Dec 31, 2008 | $47.20B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $129.80B | +10.4% |
| Q1 FY2026 | Mar 31, 2026 | $128.69B | +11.8% |
| Q4 FY2025 | Dec 31, 2025 | $136.87B | +16.9% |
| Q3 FY2025 | Sep 30, 2025 | $129.55B | +10.2% |
| Q2 FY2025 | Jun 30, 2025 | $117.52B | +4.3% |
| Q1 FY2025 | Mar 31, 2025 | $115.12B | +8.8% |
| Q4 FY2024 | Dec 31, 2024 | $117.11B | +9.8% |
| Q3 FY2024 | Sep 30, 2024 | $117.53B | +10.1% |
| Q2 FY2024 | Jun 30, 2024 | $112.63B | +7.8% |
| Q1 FY2024 | Mar 31, 2024 | $105.85B | -1.8% |
| Q4 FY2023 | Dec 31, 2023 | $106.68B | -2.3% |
| Q3 FY2023 | Sep 30, 2023 | $106.73B | -0.3% |
| Q2 FY2023 | Jun 30, 2023 | $104.47B | -2.5% |
| Q1 FY2023 | Mar 31, 2023 | $107.80B | +1.1% |
| Q4 FY2022 | Dec 31, 2022 | $109.16B | +3.3% |
| Q3 FY2022 | Sep 30, 2022 | $107.08B | +14.5% |
| Q2 FY2022 | Jun 30, 2022 | $107.10B | +18.1% |
| Q1 FY2022 | Mar 31, 2022 | $106.67B | +17.4% |
| Q4 FY2021 | Dec 31, 2021 | $105.69B | +15.4% |
| Q3 FY2021 | Sep 30, 2021 | $93.49B | +4.1% |
| Q2 FY2021 | Jun 30, 2021 | $90.69B | +0.1% |
| Q1 FY2021 | Mar 31, 2021 | $90.85B | +7.0% |
| Q4 FY2020 | Dec 31, 2020 | $91.59B | +8.5% |
| Q3 FY2020 | Sep 30, 2020 | $89.80B | +7.8% |
| Q2 FY2020 | Jun 30, 2020 | $90.62B | +7.9% |
| Q1 FY2020 | Mar 31, 2020 | $84.91B | +3.1% |
| Q4 FY2019 | Dec 31, 2019 | $84.40B | +2.1% |
| Q3 FY2019 | Sep 30, 2019 | $83.33B | -2.1% |
| Q2 FY2019 | Jun 30, 2019 | $83.97B | -1.3% |
| Q1 FY2019 | Mar 31, 2019 | $82.35B | -4.3% |
| Q4 FY2018 | Dec 31, 2018 | $82.64B | -6.0% |
| Q3 FY2018 | Sep 30, 2018 | $85.13B | -7.1% |
| Q2 FY2018 | Jun 30, 2018 | $85.04B | -8.4% |
| Q1 FY2018 | Mar 31, 2018 | $86.04B | -10.9% |
| Q4 FY2017 | Dec 31, 2017 | $87.87B | -7.9% |
| Q3 FY2017 | Sep 30, 2017 | $91.68B | -6.8% |
| Q2 FY2017 | Jun 30, 2017 | $92.80B | – |
| Q1 FY2017 | Mar 31, 2017 | $96.56B | – |
| Q4 FY2016 | Dec 31, 2016 | $95.38B | – |
| Q3 FY2016 | Sep 30, 2016 | $98.34B | – |
See a number that looks wrong?